DELFI Diagnostics’ Post

Principle 1/12: Universal detection will END CANCER Here is why: 80% of cancer deaths are avoidable through early detection. That’s 480,000 avoidable American deaths EACH YEAR. But to get there, we need universal cancer detection across ALL cancers, for ALL people. Our current standard of care isn’t anywhere close. It screens for breast, cervical and colorectal cancer too late and too infrequent. The result: hundreds of thousands of people keep dying every year. To achieve universal cancer detection would be the BIGGEST LEAP in modern medicine. And a trillion dollars in annual cancer costs could be saved worldwide. I will post the 12 Principles of Cancer Detection over the next days to outline our PATH TO UNIVERSAL DETECTION - and how we get started TODAY. Comment below and I will respond. Follow me on X to see all 12 principles first: x.com/jobhakdi Also, invest in Quantgene: https://lnkd.in/g32pcNQt #Quantgene #pioneerland

🔬 Researchers from the Johns Hopkins Kimmel Cancer Center have developed a machine learning (ML)-based liquid biopsy approach that identifies lung cancer risk via analyses of DNA fragments in the blood. The American Cancer Society indicates that lung cancer is the leading cause of cancer death in the US, accounting for roughly one-fifth of total cancer deaths annually. The organization estimates that in 2024 alone, there will be 234,580 new cases of lung cancer and 125,070 lung cancer-related deaths. To improve outcomes, the US Preventive Services Task Force (USPSTF) recommends that individuals aged 50 to 80 with relevant smoking history be screened for lung cancer yearly with low-dose computed tomography (LDCT). Annual screening helps detect cancer early, allowing patients to pursue care when the disease is most treatable. 🌍❤️ #LungCancerAwareness #MedicalInnovation #EarlyDetection #HealthTech #CancerResearch #Biopsy #MachineLearning #LiquidBiopsy #CancerPrevention #MedicalBreakthrough #HealthcareInnovation #LungCancerScreening

Adding multi-cancer early detection (MCED) testing has the potential to advance the way we screen for cancer. Don’t miss our upcoming webinar with Dr. Adrienne Perkins where you’ll dive deep into the current state of cancer screening, the discovery that led to the development of the Galleri test, and the promising role of MCED testing in addressing unmet needs. Register now: https://lnkd.in/g79G_w5D See Important Safety Information: http://bit.ly/33m8pFa The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur. Galleri should be used in addition to healthcare provider recommended screening tests. #MultiCancerEarlyDetection #CancerScreening

Screening plays a huge role in improving outcomes and early cancer diagnosis rates – the earlier someone is diagnosed, the better their chances are of survival. Identifying eligible patients and encouraging uptake will be key. RAIDR's Primary Care dashboard utilises data from clinical systems and presents the information in easy to understand, interactive visualisations – enabling users to create their own eligible cohorts and cross-reference patient lists to identify those who have not yet had the relevant cancer screening exams. #ThinkRAIDR #CervicalCancerPreventionWeek

LungLife AI CEO Paul Pagano joined Steve Darling from Proactive to discussed the groundbreaking #lungcancer detection technology developed by the company during an interview with Steve Darling from Proactive. LungLife AI is dedicated to addressing the critical issue of early detection in lung cancer, which remains the leading cause of cancer-related deaths. Dr. Pagano highlighted the sobering statistic that 80% of lung cancer cases are detected too late, contributing to the high mortality rate associated with this disease. The company's lung lb test, which has recently undergone successful validation, is poised to revolutionize the early detection of lung cancer by addressing the challenge of evaluating small nodules under 15 millimetres in size. Early intervention is crucial in improving patient outcomes, and the lung lb test is designed to meet this unmet need. Watch at #Proactive #ProactiveInvestors #AIM #LLAI http://ow.ly/8Qky1058EnE

January is #CervicalCancerMonth. 🗓️ Join us in advancing #research and knowledge about cervical cancer with some of our published papers surrounding this important topic: Clinical Decision Support System for Cervical Cancer Risk Assessment: Development & Evaluation Study - https://bit.ly/3vBN8sg Implementing Smartphone-Based Telemedicine for Cervical Cancer Screening in Uganda: Qualitative Study of Stakeholders’ Perceptions - https://bit.ly/48rj5C5 Impact of FightHPV Mobile Game on Cervical Cancer Screening Attendance: Retrospective Cohort Study - https://bit.ly/48F4WkQ Usability and Satisfaction Testing of Game-Based Learning Avatar-Navigated Mobile (GLAm), an App for Cervical Cancer Screening: Mixed Methods Study - https://bit.ly/47vf1zq

Dads are a source of strength and love in our families. When adding multicancer early detection tests like Galleri, our father figures can feel confident they’re doing more to screen for cancer. Learn more at Galleri.com. #FathersDay #GalleriTest See Important Safety Information: bit.ly/33m8pFa Galleri is a screening test and does not diagnose cancer. Diagnostic testing is needed to confirm cancer. Galleri should be used in addition to healthcare provider recommended screening tests. The Galleri test does not detect a signal for all cancers and not all cancers can be detected in the blood. False positive and false negative results do occur.

 I was truly excited to see this news circulating. Having always been deeply fascinated by cancer research and having lost loved ones to this disease, I am intrigued by the possibilities that lie ahead. Imagine a future where our body’s defenses can be programmed to target unique tumor characteristics. The idea of personalized cancer vaccines tailored to an individual’s tumor, or even off-the-shelf options for common cancer types, brings immense hope and curiosity. After witnessing the rapid development of the COVID-19 vaccine and it's impact on global health, I am eager to see the innovative platforms and delivery methods that will emerge from this initiative. #cancerresearch #personalizedmedicine #mRNAvaccines #NHS #Hope You can read more about this exciting development here:  https://lnkd.in/dA9vFXfg https://lnkd.in/davyWfyk https://lnkd.in/dmJA8SZW https://lnkd.in/df7D8y4q  

This week, the American Cancer Society released its Cancer Facts and Figures for 2024, projecting more than 2 million new cancer cases this year for the first time ever. At AcuamarkDx, we’re responding to this important challenge by advancing our novel technology for early cancer detection and frequent recurrence monitoring. Our innovative approach detects cancer-specific DNA methylation with PCR technology, making early-cancer detection as easy as an in-clinic COVID test. We’re more motivated than ever by the latest findings and the increasing need for early detection methods that are first and foremost reliable, but also cost-effective, accessible and efficient for patients and physicians. #CancerResearch #EarlyDetection #Innovation #AcuamarkDx

🚨 It's time to clear the lung cancer smoke screen 🚨 "No one should have to die, period." Changing the narrative around lung cancer saves lives! 🤝 Body Vision stands in solidarity with Alicia Zhou, PhD, who published an article for Med City News on the importance of ending the undue stigma.  ❌ THE PROBLEM ❌ - Lung cancer claims more lives than breast, colorectal, and prostate cancer combined. - Yet, the number of high-risk individuals who partake in lung cancer screening is alarmingly low (only 6%). - Largely because it's often mischaracterized as self-inflicted by people who smoke. ✅ THE SOLUTION ✅ - Rewrite the story and break the pattern of judgement. - Spread the word that LDCT screening is fast, easy, and non-invasive. With LungVision™ AI-driven image guidance, we're making top-tier lung cancer diagnostics accessible and breaking barriers for patients everywhere 🏥 Together, we can redefine lung health. Your health matters, your screening matters, and your story matters. Check out our page and hit "Follow" to stay ahead of the curve ⤴ #LungCancerAwareness #aihealthcare #pulmonologist #medtech